THE manufacturers of Arimidex, a rival drug to frontline breast cancer drug tamoxifen, claim their product helps women live cancer-free for longer.

A STUDY has confirmed that women with early breast cancer get significant benefits from taking the new drug Arimidex.

A newer drug clearly outperforms tamoxifen at preventing breast cancer from returning and should become the first-choice treatment for most women who have had the disease, doctors are reporting.

FINDING a cure for cancer came two steps closer to reality last night with the publication of ground-breaking research, an Irish oncology expert said.